Photo from Rami Komrokji/Twitter
Jun 7, 2024, 12:04
Rami Komrokji: Imetelstat approved for MDS patients
Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center, shared a post on X: .
“I am so honored to be part of this journey as a senior clinical investigator and having presented the data to the ODAC (Oncologic Drugs Advisory Committee) FDA committee to get Imetelstat approved to hopefully help many of our MDS (Myelodysplastic syndromes) patients.”
Read Further.
Source: Rami Komrokji/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14